TORONTO, June 05, 2026 (GLOBE NEWSWIRE) — McFarlane Lake Mining Limited (“McFarlane” or the “Company”) (CSE: MLM, OTC: MLMLF) announces the continuation and renewal of its investor relations and marketing service engagements with Alliance Advisors Investor Relations (“Alliance Advisors IR”), The Market Link (“Market Link”) and Emerging Markets Consulting (“EMC”). The Market Link Further to the marketing services agreement entered into on November 14, 2025 with The Market Link, the Company and The Market Link entered into an extension of the arrangement for an additional four-month term on March 19, 2026 for total cash compensation of US$110,000. For more information regarding the services provided by The Market Link, refer to the Company’s press release dated January 19, 2026. Emerging Markets Consulting The Company entered into...

$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash, it is anticipated that the cash runway would extend well beyond FDA approval and first full year of commercialization ACTON, Mass., June 05, 2026 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on near-patient testing for critical care, today announced the closing of its previously announced private placement for the purchase and sale of an aggregate of 3,655,917 shares of common stock (or pre-funded warrant in lieu thereof), series G warrants to purchase up to 3,655,917...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. VANCOUVER, British Columbia, June 05, 2026 (GLOBE NEWSWIRE) — Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”) is pleased to announce a non-brokered private placement offering (the “Offering”) of up to 1,500,000 units (the “Units”) at a price of $1.00 per Unit for aggregate gross proceeds of up to $1,500,000. The Offering Each Unit will be comprised of one common share of the Company (a “Common Share”) and one transferable Common Share purchase warrant (a “Warrant”). Each Warrant entitles the holder to purchase one additional Common Share at a price of $2.00 per Common Share for a period of three years from the closing of...

Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type 1 and type 2 diabetes New data and real-world findings further emphasize pediatric safety, glycemic control and treatment satisfaction Exploratory analysis of inhaled insulin used with AID systems provides insight on the impact of total daily dose algorithms Data from randomized cross-over trial supports safety and efficacy of inhaled insulin as an alternative to RAA in gestational diabetesDANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 05, 2026 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for cardiometabolic and orphan lung diseases, today announced new clinical and real‑world...

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a once-weekly injection and a once-daily oral pill for the treatment of obesity and overweight Additional data from Phase 2 obesity clinical trial of ribupatide oral demonstrating mean weight loss of up to 12.1% with no observed plateau and up to 38.6% of participants achieving at least 15% weight loss at 26 weeks; incidence of gastrointestinal adverse events was low, with vomiting reported in 11.4% and 7.5% of participants taking 25 mg and 50 mg ribupatide oral, respectively Phase 1 single ascending dose trial, the first ribupatide injection clinical data generated outside of China, demonstrated similar exposure, tolerability, and weight reduction in participants of Asian and non-Asian descentSHANGHAI and WALTHAM, Mass.,...

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 receptor agonists to enhance metabolic health outcomes • Clinical data presented at ADA from COVALENT-112 show improvements in HbA1c and C-peptide in type 1 diabetes patients treated with icovamenib, with no evidence of immune activation, and inflammatory markers stable or reduced • Additionally, the Company expanded its Phase I BMF-650 study to evaluate a rapid one-step titration and enhanced weight loss potential with its oral GLP-1 receptor agonist SAN CARLOS, Calif., June 05, 2026 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes...

MONTREAL, June 05, 2026 (GLOBE NEWSWIRE) — This press release is disseminated by Knight Therapeutics Inc. (“Knight”) (TSX:GUD), a pan-American (ex-US) pharmaceutical company, as required by Regulation 62-103 respecting the Early Warning System and Related Take-Over Bid and Insider Reporting Issues regarding securities of Crescita Therapeutics Inc. (“Crescita”).  Crescita has announced the closing of the previously announced plan of arrangement (the “Arrangement”) with ClinActiv Holdings Inc. (“ClinActiv”) and its wholly-owned subsidiary (the “Purchaser”), pursuant to which the Purchaser acquired all the issued and outstanding common shares of Crescita (the “Shares”) in exchange for a cash consideration of $0.80 per Share.  Prior to the closing of the Arrangement, Knight had control over 1,935,489 Shares representing approximately...

GUADALAJARA, Mexico, June 05, 2026 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger traffic figures for May 2026, compared with May 2025. During May 2026, the 12 Mexican airports operated by GAP recorded a 2.8% decrease in total passenger traffic compared to May 2025. Guadalajara airport reported an increase of 7.1%, while Puerto Vallarta, Tijuana and Los Cabos reported a decrease of 14.4%, 9.8%, and 6.0%, respectively, compared to May 2025. With respect to GAP’s airports in Jamaica, Montego Bay recorded a decrease of 19.1%, while Montego Bay recorded a decrease of 5.2%.Domestic Terminal Passengers (in thousands):             Airport May-25 May-26 % Change Jan – May 25 Jan – May 26 % ChangeGuadalajara 1,023.4 1,085.9 6.1% 5,112.0 5,187.7 1.5%Tijuana* 730.5 664.5 (9.0%) 3,536.6 3,304.7 (6.6%)Los...

TORTOLA, British Virgin Islands, June 05, 2026 (GLOBE NEWSWIRE) — Orca Energy Group Inc. (“Orca” or the “Company” and includes its subsidiaries and affiliates) (TSX-V: ORC.A, ORC.B) today announces that it has filed its condensed consolidated interim (unaudited) financial statements and management’s discussion and analysis for the three month period ended March 31, 2026 (“Q1 2026”) with the Canadian securities regulatory authorities. All amounts are in United States dollars (“$”) unless otherwise stated. HighlightsRevenue for Q1 2026 increased by $3.0 million (12%) compared to the same prior year period, primarily as a result of a higher volumes, partially offset by the increase in the Tanzanian Petroleum Development Corporation (“TPDC”) share of revenue. Additional Gas volumes increased by 7.7 MMcfd (11%) for Q1 2026 compared...

VANCOUVER, British Columbia, June 05, 2026 (GLOBE NEWSWIRE) — Blue Jay Gold Corp. (TSXV: JAY) (“Blue Jay” or the “Company”), announces two concurrent capital markets engagements: (i) the retention of Oak Hill Financial Inc. (“Oak Hill”) to provide business and capital markets advisory services including investor relations, effective June 5, 2026; and (ii) the retention of Haywood Securities Inc. (“Haywood”) to provide market-making services for the common shares of the Company, effective June 4, 2026. Oak Hill Financial Inc. – Investor Relations Advisory Oak Hill will provide business and capital markets advisory services, including raising the Company’s profile with the investment community, assisting in the development and dissemination of investor presentation materials, and delivering regular monthly progress reports. The initial...